Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Reham G. Elsaady"'
Alzheimer’s disease (AD) is one of the leading causes of dependence and disability among the elderly worldwide. The traditional anti-Alzheimer medication, rivastigmine, one of the cholinesterase inhibitors (ChEIs), fails to achieve a definitive cur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::49f94d6a438a6e42134f202958110f84
https://doi.org/10.21203/rs.3.rs-831722/v1
https://doi.org/10.21203/rs.3.rs-831722/v1
Publikováno v:
European journal of pharmacology. 915
Alzheimer's disease (AD) is one of the leading causes of dependence and disability among the elderly worldwide. The traditional anti-Alzheimer medication, rivastigmine, one of the cholinesterase inhibitors (ChEIs), fails to achieve a definitive cure.